DANIEL CLAYTON MORSE
Allopathic & Osteopathic Physicians|Dermatology NEW YORK, NY NPI 1053975995
Browse related groups: Allopathic & Osteopathic Physicians|Dermatology NY Arcutis Biotherapeutics, Inc. All categories
General Payments — all program years on this page
$609.74
- Category: General Payments
- Program years: PY2023–2024
- Record count: 13
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $367.68 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $367.68 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | $172.96 | 5 |
| Amgen Inc. | $114.80 | 2 |
| Novo Nordisk AS | $79.92 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1096815379 | Novo Nordisk Inc | $79.92 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117333410 | Amgen Inc. | $62.18 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117333412 | Amgen Inc. | $52.62 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1121042386 | Arcutis Biotherapeutics, Inc. | $7.48 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1121042388 | Arcutis Biotherapeutics, Inc. | $14.57 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1121042390 | Arcutis Biotherapeutics, Inc. | $22.56 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1121042392 | Arcutis Biotherapeutics, Inc. | $8.50 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1121042394 | Arcutis Biotherapeutics, Inc. | $119.85 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.